- Frontage Laboratories (FTHCY, Financial) launches a new 46,300-square-foot GMP CRDMO facility in Exton, Pennsylvania.
- The state-of-the-art facility includes nine specialized GMP suites and comprehensive labs for diverse manufacturing capabilities.
- This expansion reinforces Frontage's position as a one-stop solution provider for pharmaceutical and biotech clients.
Frontage Laboratories (FTHCY) has officially launched a new 46,300-square-foot Good Manufacturing Practice (GMP) Contract Research, Development, and Manufacturing Organization (CRDMO) facility in Exton, Pennsylvania. The grand opening event took place on May 22, 2025, marking a significant milestone in the company's expansion of its pharmaceutical and biotech services.
The new facility boasts nine GMP suites, consisting of two high-potent suites, two aseptic suites, and five non-sterile suites. These suites support the manufacturing of a variety of pharmaceutical formulations, including injectables, tablets, capsules, creams, gels, ointments, and ophthalmic and nasal preparations. Additionally, the facility is equipped with two formulation development labs and three analytical labs, including a micro lab, to support comprehensive processes from drug development to clinical trial support.
Dr. Song Li, Founder and Executive Chairman of Frontage, expressed gratitude to those who attended the event, highlighting the facility as a significant enhancement to their offerings in the CDMO and clinical trial material supply sectors. Dr. Wentao Zhang, Co-CEO of Frontage, added that the state-of-the-art facility strategically positions Frontage closer to its clients, enhancing their ability to meet evolving development and supply needs efficiently.
This expansion complements Frontage's existing array of services, which includes drug substance synthesis, DMPK, safety & toxicology studies, bioanalysis, and clinical trial support. With this new facility, Frontage reinforces its role as a comprehensive, one-stop solution provider, strengthening its market position in the CDMO space.
